Drug Trial Radar · NCT04447469
Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation
Last checked: Nov 19, 2026Latest source record: Jan 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
814
Actual
Start
Jul 28, 2020
Primary completion
Nov 12, 2021
Study completion Jan 14, 2022
Sponsor
- Lead sponsor
- Kiniksa Pharmaceuticals International, plcIndustry
- Sponsor type
- Industry
- Collaborators
- Kiniksa Pharmaceuticals, Ltd.
- First posted
- Jun 25, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Interventional, randomized, double-blind, placebo-controlled study encompassing 2 development phases (Phase 2 and Phase 3).
Conditions
- COVID
Interventions
mavrilimumabDrug
anti-granulocyte-macrophage colony-stimulating factor receptor alpha (GM-CSF-Rα) monoclonal antibody (human isoform immunoglobulin G \[IgG4\])
PlaceboOther
matching placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cohort 1, Phase 2: Percentage of Participants Alive and Free of Mechanical Ventilation at Day 29Time frame: Day 29
- Cohort 1, Phase 3: Percentage of Participants Alive and Free of Mechanical Ventilation at Day 29Time frame: Day 29
- Cohort 2, Phase 2: Percentage of Participants Who Died by Day 29Time frame: Day 29
- Cohort 2, Phase 3: Percentage of Participants Who Died by Day 29Time frame: Day 29
Locations
32 sites in 5 countries. Site status is shown where the registry gives one.
UCLA Medical Center
Los Angeles, California
SHARP Health Care
San Diego, California
Affinity Health
Chicago, Illinois
Tulane University School of Medicine
New Orleans, Louisiana
Allina Health System
Minneapolis, Minnesota
Mercy Clinic Hospitalists
Springfield, Missouri
University of Cincinnati
Cincinnati, Ohio
Bryn Mawr Hospital
Bryn Mawr, Pennsylvania
University of Texas Health Sciences
Houston, Texas
Hospital Adventista de Belem
Belém, Brazil
IEP HGF - Instituto de Estudos e Pesquisas Clinicas do Ceará
Fortaleza, Brazil
Fundação Faculdade Regional de Medicina de São José do Rio Preto
São José, Brazil
Hospital Alemão Oswaldo Cruz
São Paulo, Brazil
Hospital Cardio Pulmonar
Salvador, Estado de Bahia, Brazil
Hospital Luxemburgo - Associação Mário Penna
Belo Horizonte, Minas Gerais, Brazil
CPCLIN - Centro de Pesquisas Clínicas
Natal, Rio Grande do Norte, Brazil
Hospital Bruno Born
Lajeado, Rio Grande do Sul, Brazil
UPECLIN - Unidade de Pesquisa Clínica
Botucatu, São Paulo, Brazil
IPECC - Instituto de Pesquisa Clínica de Campinas
Campinas, São Paulo, Brazil
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Ribeirão Preto, São Paulo, Brazil
Clinica Las Condes
Santiago, Chile
Hospital Clinico Universidad de Chile
Santiago, Chile
Hospital Nacional Alberto Sabogal Sologuren
Bellavista, Peru
Essalud - Hospital de Emergencias Grau
Lima Cercado, Peru
Hospital Nacional Cayetano Heredia
San Martín de Porres, Peru
Clinica Providencia
San Miguel, Peru
IATROS International
Bloemfontein, South Africa
Tiervlei Trial Center
Cape Town, South Africa
TASK Eden
George, South Africa
Into Research - Little Company of Mary Medical Center
Pretoria, South Africa
Limpopo Clinical Research Initiative
Rustenburg, South Africa
University of Cape Town - Lung Institute
Cape Town, Western Cape, South Africa
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.